Ads
    Related conference
  1. Role of Soluble FMS-Like Tyrosine Kinase (SFLT-1) /Placental Growth Factor (Plgf) Ratio as Prognostic Marker for Cases of Preeclampsia
  2. Differentiating Maternal Angiogenesis Factors between Early and Late Onset Preeclampsia: Higher sflt-1 in Early Onset Preeclampsia, Lower PlGF and Higher sflt-1/PlGF Ratio in Late Onset Preeclampsia
  3. PlGF, sFlt-1 and sFlt-1/PlGF ratio: Promising markers for predicting pre-eclampsia
  4. Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
  5. Role of LDH (Lactate dehydrogenase) in preeclampsia ? eclampsia as a prognostic marker: An observational study
  6. Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
  7. Structure-Based Identification of Some Potential Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) With In-silico Assessment of Their Pharmacokinetic Features and Quantum Chemical Calculations
  8. CATHEPSIN B AS FUTURE PROGNOSTIC MARKER IN CASES OF GLIOMA
  9. High Level of Maternal Low Density Lypoprotein and Insulin-Like Growth Factor Binding Protein 5 as a Risk Factor for Preeclampsia
  10. In silico screening of 3,4 dihydropyrimidones as focal adhesion tyrosine kinase inhibitors